Avalo Therapeutics, Inc.

NasdaqCM:AVTX Stock Report

Mkt Cap: US$47.1m

Avalo Therapeutics Company Information

Avalo Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Avalo Therapeutics, Inc.
  • Ticker: AVTX
  • Exchange: NasdaqCM
  • Founded: 2011
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$47.071m
  • Shares outstanding: 9.41m
  • Website: https://www.avalotx.com

Number of Employees


  • Avalo Therapeutics, Inc.
  • 540 Gaither Road
  • Suite 400
  • Rockville
  • Maryland
  • 20850
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDNov 2015
C6KDB (Deutsche Boerse AG)YesCommon StockDEEURNov 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/18 00:00
End of Day Share Price2023/01/17 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.